<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01454037</url>
  </required_header>
  <id_info>
    <org_study_id>201107059RB</org_study_id>
    <nct_id>NCT01454037</nct_id>
  </id_info>
  <brief_title>Immune Profiles and Circulating Tumor Cell Status Following Prostate Cryotherapy</brief_title>
  <official_title>Immune Profiles and Circulating Tumor Cell Status Following Prostate Cryotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      The change of immune profiles and existence of circulating tumor cells following prostate
      cryotherapy may be correlated with the clinical outcome.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cancer recurrence</measure>
    <time_frame>3, 6, 12, 24 months after treatments</time_frame>
    <description>Includes:
Biochemical (PSA) recurrence according to the ASTRO or Phoenix criteria for patients undergoing cryotherapy (Cryo) or radiotherapy (RT)
Prostate biopsy positivity
Radiographic evidence of recurrence (CT/MRI, Bone scan, radiographs, etc.) Time to recurrence defined by the either of the above 3 outcome parameters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3, 6, 12, 24months after treatments</time_frame>
    <description>according to the QLQ C30 and PR25 questionnaire interview</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Immune Profile</condition>
  <condition>Circulating Cancer Cells</condition>
  <condition>Clinical Corelation</condition>
  <arm_group>
    <arm_group_label>Prostate cryoablation</arm_group_label>
    <description>Subjects receiving cryotherapy for prostate cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radical prostatectomy</arm_group_label>
    <description>Subjects receiving radical prostatectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiation</arm_group_label>
    <description>Subjects receiving radiation for prostate cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Prostate cryotherapy</intervention_name>
    <description>cryoablate the prostate</description>
    <arm_group_label>Prostate cryoablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radical prostatectomy</intervention_name>
    <description>Remove prostate</description>
    <arm_group_label>Radical prostatectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiation</intervention_name>
    <description>Radiate prostate</description>
    <arm_group_label>Radiation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Taiwanese organ-confined or locally advanced prostate cancer patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;20 years

          -  Histopathology-proven prostate adenocarcinoma

          -  Non-metastatic localized disease

          -  Subjects have chosen their curative, definitive treatments for prostate cancer prior
             to enrolling for the study

          -  Subjects are willing to sign the informed consent and agree to comply with the study
             procedures

        Exclusion Criteria:

          -  Chronic use (&gt; 2 weeks) of &gt; 10 mg/day of prednisone or prednisolone within 2 months
             of the screening (topical or inhalational corticosteroids are permitted)

          -  Concurrent use of immunosuppressive therapy, including: cyclosporine, antithymocyte
             globulin, or tacrolimus within 3 months of study entry

          -  Other conditions the investigators think may affect subjects' compliance
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yeong-Shiau Pu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yeong-Shiau Pu, PhD</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>65249</phone_ext>
    <email>yspu@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yeong-Shiau Pu, PhD</last_name>
      <phone>886-2-23123456</phone>
      <phone_ext>65249</phone_ext>
      <email>yspu@ntu.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Yeong-Shiau Pu, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chung-Hsin Chen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>HJ Yu, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>CY Huang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>SM Wang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>HC Tai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>SP Lui, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>WJ Lin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>JS Chen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2011</study_first_submitted>
  <study_first_submitted_qc>October 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2011</study_first_posted>
  <last_update_submitted>November 12, 2012</last_update_submitted>
  <last_update_submitted_qc>November 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplastic Cells, Circulating</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

